Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-09-19

FDA Approved: ENALAPRIL MALEATE — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved the generic enalapril maleate from Rising Pharma Holdings under an Original Application (ANDA 218531).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Enalapril maleate (enalapril maleate)

Snippet

ORIG AP for ENALAPRIL MALEATE (ENALAPRIL MALEATE)